Does DOSTARLIMAB Cause Tubulointerstitial nephritis? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Tubulointerstitial nephritis have been filed in association with DOSTARLIMAB (Jemperli). This represents 0.8% of all adverse event reports for DOSTARLIMAB.
7
Reports of Tubulointerstitial nephritis with DOSTARLIMAB
0.8%
of all DOSTARLIMAB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Tubulointerstitial nephritis From DOSTARLIMAB?
Of the 7 reports, 3 (42.9%) required hospitalization, and 1 (14.3%) were considered life-threatening.
Is Tubulointerstitial nephritis Listed in the Official Label?
Yes, Tubulointerstitial nephritis is listed as a known adverse reaction in the official FDA drug label for DOSTARLIMAB.
What Other Side Effects Does DOSTARLIMAB Cause?
Malignant neoplasm progression (111)
Thrombocytopenia (42)
Fatigue (38)
Anaemia (36)
Death (31)
Arthralgia (30)
Diarrhoea (29)
Rash (29)
Condition aggravated (27)
Dyspnoea (26)
What Other Drugs Cause Tubulointerstitial nephritis?
OMEPRAZOLE (4,809)
ESOMEPRAZOLE (4,024)
LANSOPRAZOLE (3,860)
PANTOPRAZOLE (3,590)
DEXLANSOPRAZOLE (2,177)
RABEPRAZOLE (1,125)
PEMBROLIZUMAB (860)
IBUPROFEN (844)
VANCOMYCIN (523)
TACROLIMUS (486)
Which DOSTARLIMAB Alternatives Have Lower Tubulointerstitial nephritis Risk?
DOSTARLIMAB vs DOSTARLIMAB-GXLY
DOSTARLIMAB vs DOTATATE GALLIUM GA-68
DOSTARLIMAB vs DOTHIEPIN
DOSTARLIMAB vs DOXAZOSIN
DOSTARLIMAB vs DOXAZOSIN\DOXAZOSIN